• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

S6结构域中芳香族残基的位置而非失活决定了HERG和eag钾通道对西沙必利的敏感性。

Position of aromatic residues in the S6 domain, not inactivation, dictates cisapride sensitivity of HERG and eag potassium channels.

作者信息

Chen Jun, Seebohm Guiscard, Sanguinetti Michael C

机构信息

Department of Internal Medicine, University of Utah, 15 North 2030 East, Room 4220, Salt Lake City, UT 84112, USA.

出版信息

Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12461-6. doi: 10.1073/pnas.192367299. Epub 2002 Sep 3.

DOI:10.1073/pnas.192367299
PMID:12209010
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC129467/
Abstract

Unintended block of HERG K+ channels is a side effect of many common medications and is the most common cause of acquired long QT syndrome associated with increased risk of life-threatening arrhythmias. The molecular mechanism of high-affinity HERG block by structurally diverse compounds has been attributed to pi-stacking and cation-pi interactions of a drug (e.g., cisapride) with specific aromatic amino acid residues (Tyr-652 and Phe-656) in the S6 alpha-helical domain that face the central cavity of the channel. It also has been proposed that strong C-type inactivation of HERG facilitates or is the primary determinant of high-affinity drug binding. The structurally related, but noninactivating eag channel is insensitive to HERG blockers unless inactivation is induced by specific amino acid mutations [Ficker, E., Jarolimek, W. & Brown, A. M. (2001) Mol. Pharmacol. 60, 1343-1348]. Here we examine the relative importance of inactivation vs. positioning of S6 aromatic residues in determining sensitivity of HERG and eag channels to block by cisapride. The repositioning of Tyr-652 or Phe-656 along the S6 alpha-helical domain of HERG reduced sensitivity of channels to block by cisapride. Moreover, independent of inactivation, repositioning of the equivalent aromatic residues in Drosophila eag channels induced sensitivity to block by cisapride. These findings suggest that positioning of S6 aromatic residues relative to the central cavity of the channel, not inactivation per se determines drug block of HERG or eag channels.

摘要

许多常用药物的副作用是意外阻断HERG钾通道,这也是获得性长QT综合征最常见的病因,会增加危及生命的心律失常风险。结构多样的化合物对HERG的高亲和力阻断的分子机制,被认为是药物(如西沙必利)与S6α-螺旋结构域中面对通道中心腔的特定芳香族氨基酸残基(Tyr-652和Phe-656)之间的π-堆积和阳离子-π相互作用。也有人提出,HERG强烈的C型失活促进或决定了高亲和力药物结合。结构相关但不发生失活的eag通道对HERG阻断剂不敏感,除非通过特定氨基酸突变诱导失活[Ficker, E., Jarolimek, W. & Brown, A. M. (2001) Mol. Pharmacol. 60, 1343 - 1348]。在这里,我们研究了失活与S6芳香族残基定位在决定HERG和eag通道对西沙必利阻断敏感性方面的相对重要性。HERG的S6α-螺旋结构域中Tyr-652或Phe-656的重新定位降低了通道对西沙必利阻断的敏感性。此外,独立于失活情况,果蝇eag通道中等效芳香族残基的重新定位诱导了对西沙必利阻断的敏感性。这些发现表明,相对于通道中心腔的S6芳香族残基的定位,而非失活本身决定了HERG或eag通道的药物阻断。

相似文献

1
Position of aromatic residues in the S6 domain, not inactivation, dictates cisapride sensitivity of HERG and eag potassium channels.S6结构域中芳香族残基的位置而非失活决定了HERG和eag钾通道对西沙必利的敏感性。
Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12461-6. doi: 10.1073/pnas.192367299. Epub 2002 Sep 3.
2
Transfer of rapid inactivation and sensitivity to the class III antiarrhythmic drug E-4031 from HERG to M-eag channels.快速失活特性及对Ⅲ类抗心律失常药物E-4031的敏感性从HERG通道向M-eag通道的转移。
J Physiol. 1998 Aug 15;511 ( Pt 1)(Pt 1):3-14. doi: 10.1111/j.1469-7793.1998.003bi.x.
3
A structural basis for drug-induced long QT syndrome.药物诱导性长QT综合征的结构基础。
Proc Natl Acad Sci U S A. 2000 Oct 24;97(22):12329-33. doi: 10.1073/pnas.210244497.
4
Molecular determinants of dofetilide block of HERG K+ channels.决奈达隆对HERG钾通道阻滞作用的分子决定因素
Circ Res. 1998 Feb 23;82(3):386-95. doi: 10.1161/01.res.82.3.386.
5
Physicochemical features of the HERG channel drug binding site.HERG通道药物结合位点的物理化学特征。
J Biol Chem. 2004 Mar 12;279(11):10120-7. doi: 10.1074/jbc.M310683200. Epub 2003 Dec 29.
6
Molecular determinants of voltage-dependent human ether-a-go-go related gene (HERG) K+ channel block.电压依赖性人类醚孔相关基因(HERG)钾通道阻滞的分子决定因素。
J Biol Chem. 2002 Jun 28;277(26):23587-95. doi: 10.1074/jbc.M200448200. Epub 2002 Apr 17.
7
Effects of outer mouth mutations on hERG channel function: a comparison with similar mutations in the Shaker channel.外口突变对hERG通道功能的影响:与Shaker通道中类似突变的比较。
Biophys J. 1999 Jun;76(6):3128-40. doi: 10.1016/S0006-3495(99)77464-3.
8
The binding site for channel blockers that rescue misprocessed human long QT syndrome type 2 ether-a-gogo-related gene (HERG) mutations.可挽救错误加工的人类长QT综合征2型醚-去极化相关基因(HERG)突变的通道阻滞剂结合位点。
J Biol Chem. 2002 Feb 15;277(7):4989-98. doi: 10.1074/jbc.M107345200. Epub 2001 Dec 10.
9
Open channel block of HERG K(+) channels by vesnarinone.维司力农对HERG钾通道的开放通道阻滞作用
Mol Pharmacol. 2001 Aug;60(2):244-53. doi: 10.1124/mol.60.2.244.
10
Voltage-dependent profile of human ether-a-go-go-related gene channel block is influenced by a single residue in the S6 transmembrane domain.人去极化激活延迟整流钾离子通道(hERG)通道阻滞的电压依赖性特征受S6跨膜结构域中单个残基的影响。
Mol Pharmacol. 2003 May;63(5):1051-8. doi: 10.1124/mol.63.5.1051.

引用本文的文献

1
Stereoselective block of the hERG potassium channel by the Class Ia antiarrhythmic drug disopyramide.立体选择性阻断 hERG 钾通道的 Ia 类抗心律失常药物双异丙吡胺。
Cell Mol Life Sci. 2024 Nov 28;81(1):466. doi: 10.1007/s00018-024-05498-4.
2
Structural modeling of hERG channel-drug interactions using Rosetta.使用Rosetta对人乙醚-a-去极化相关基因(hERG)通道-药物相互作用进行结构建模。
Front Pharmacol. 2023 Nov 14;14:1244166. doi: 10.3389/fphar.2023.1244166. eCollection 2023.
3
Facilitation of hERG Activation by Its Blocker: A Mechanism to Reduce Drug-Induced Proarrhythmic Risk.其阻滞剂促进 hERG 激活:降低药物致心律失常风险的一种机制。
Int J Mol Sci. 2023 Nov 13;24(22):16261. doi: 10.3390/ijms242216261.
4
Inhibition of the hERG Potassium Channel by a Methanesulphonate-Free E-4031 Analogue.一种无甲磺酸盐的E-4031类似物对人醚-去极化激活的钾通道的抑制作用。
Pharmaceuticals (Basel). 2023 Aug 24;16(9):1204. doi: 10.3390/ph16091204.
5
The Strength of hERG Inhibition by Erythromycin at Different Temperatures Might Be Due to Its Interacting Features with the Channels.红霉素在不同温度下对 hERG 的抑制作用可能与其与通道的相互作用特征有关。
Molecules. 2023 Jul 3;28(13):5176. doi: 10.3390/molecules28135176.
6
Ensemble of structure and ligand-based classification models for hERG liability profiling.用于hERG风险评估的基于结构和配体的分类模型集成
Front Pharmacol. 2023 Mar 23;14:1148670. doi: 10.3389/fphar.2023.1148670. eCollection 2023.
7
hERG Blockade Prediction by Combining Site Identification by Ligand Competitive Saturation and Physicochemical Properties.通过结合配体竞争饱和法进行位点鉴定与理化性质预测人醚 - 去极化激活的钾离子通道阻断作用
Chemistry (Basel). 2022 Sep;4(3):630-646. doi: 10.3390/chemistry4030045. Epub 2022 Jun 21.
8
Use of Solvent Mapping for Characterizing the Binding Site and for Predicting the Inhibition of the Human Ether-á-Go-Go-Related K Channel.溶剂作图在人醚-α--go-go 相关钾通道的结合部位特征化和抑制预测中的应用。
Chem Res Toxicol. 2022 Aug 15;35(8):1359-1369. doi: 10.1021/acs.chemrestox.2c00036. Epub 2022 Jul 27.
9
Structure-Based Prediction of hERG-Related Cardiotoxicity: A Benchmark Study.基于结构的 hERG 相关心脏毒性预测:基准研究。
J Chem Inf Model. 2021 Sep 27;61(9):4758-4770. doi: 10.1021/acs.jcim.1c00744. Epub 2021 Sep 10.
10
Molecular Dynamics-Derived Pharmacophore Model Explaining the Nonselective Aspect of K10.1 Pore Blockers.基于分子动力学的配体药效团模型解释 K10.1 孔阻滞剂的非选择性。
Int J Mol Sci. 2021 Aug 20;22(16):8999. doi: 10.3390/ijms22168999.

本文引用的文献

1
The open pore conformation of potassium channels.钾通道的开放孔构象。
Nature. 2002 May 30;417(6888):523-6. doi: 10.1038/417523a.
2
Crystal structure and mechanism of a calcium-gated potassium channel.钙门控钾通道的晶体结构与机制
Nature. 2002 May 30;417(6888):515-22. doi: 10.1038/417515a.
3
Molecular determinants of voltage-dependent human ether-a-go-go related gene (HERG) K+ channel block.电压依赖性人类醚孔相关基因(HERG)钾通道阻滞的分子决定因素。
J Biol Chem. 2002 Jun 28;277(26):23587-95. doi: 10.1074/jbc.M200448200. Epub 2002 Apr 17.
4
Molecular determinants of inactivation and dofetilide block in ether a-go-go (EAG) channels and EAG-related K(+) channels.醚 - 去极化(EAG)通道和EAG相关钾离子通道中失活及多非利特阻断的分子决定因素
Mol Pharmacol. 2001 Dec;60(6):1343-8. doi: 10.1124/mol.60.6.1343.
5
Structure of the KcsA channel intracellular gate in the open state.处于开放状态的钾离子通道(KcsA)胞内门控的结构。
Nat Struct Biol. 2001 Oct;8(10):883-7. doi: 10.1038/nsb1001-883.
6
Open channel block of HERG K(+) channels by vesnarinone.维司力农对HERG钾通道的开放通道阻滞作用
Mol Pharmacol. 2001 Aug;60(2):244-53. doi: 10.1124/mol.60.2.244.
7
Drugs that prolong QT interval as an unwanted effect: assessing their likelihood of inducing hazardous cardiac dysrhythmias.作为不良作用延长QT间期的药物:评估其诱发危险心脏心律失常的可能性。
Expert Opin Pharmacother. 2000 Jul;1(5):947-73. doi: 10.1517/14656566.1.5.947.
8
Molecular and cellular mechanisms of cardiac arrhythmias.心律失常的分子和细胞机制。
Cell. 2001 Feb 23;104(4):569-80. doi: 10.1016/s0092-8674(01)00243-4.
9
Inhibition of HERG potassium channel current by the class 1a antiarrhythmic agent disopyramide.1a类抗心律失常药物丙吡胺对HERG钾通道电流的抑制作用。
Biochem Biophys Res Commun. 2001 Feb 9;280(5):1243-50. doi: 10.1006/bbrc.2001.4269.
10
Probing the interaction between inactivation gating and Dd-sotalol block of HERG.探究HERG失活门控与D-索他洛尔阻断之间的相互作用。
Circ Res. 2000 Nov 24;87(11):1012-8. doi: 10.1161/01.res.87.11.1012.